Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study

por de Vos, S, Swinnen, L J, Wang, D, Reid, E, Fowler, N, Cordero, J, Dunbar, M, Enschede, S H, Nolan, C, Petrich, A M, Ross, J A, Salem, A H, Verdugo, M, Agarwal, S, Zhou, L, Kozloff, M, Nastoupil, L J, Flowers, C R
Publicado 2018